nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—Brain oedema—Carmustine—melanoma	0.0257	0.0345	CcSEcCtD
Lorazepam—Brain oedema—Temozolomide—melanoma	0.0248	0.0334	CcSEcCtD
Lorazepam—TSPO—hindlimb—melanoma	0.0244	0.198	CbGeAlD
Lorazepam—TSPO—appendage—melanoma	0.0209	0.17	CbGeAlD
Lorazepam—UGT2B15—Glucuronidation—UGT2B10—melanoma	0.0207	0.197	CbGpPWpGaD
Lorazepam—Paralysis—Vemurafenib—melanoma	0.02	0.0269	CcSEcCtD
Lorazepam—UGT2B15—Glucuronidation—UGT2B10—melanoma	0.0168	0.16	CbGpPWpGaD
Lorazepam—Diclofenac—CXCR1—melanoma	0.0144	0.523	CrCbGaD
Lorazepam—TSPO—hair follicle—melanoma	0.0124	0.101	CbGeAlD
Lorazepam—TSPO—blood vessel—melanoma	0.0117	0.0947	CbGeAlD
Lorazepam—Pericardial effusion—Docetaxel—melanoma	0.0115	0.0155	CcSEcCtD
Lorazepam—Coagulopathy—Dactinomycin—melanoma	0.0101	0.0135	CcSEcCtD
Lorazepam—Stupor—Carmustine—melanoma	0.00983	0.0132	CcSEcCtD
Lorazepam—Aggression—Bleomycin—melanoma	0.00957	0.0129	CcSEcCtD
Lorazepam—Extrapyramidal disorder—Temozolomide—melanoma	0.00942	0.0127	CcSEcCtD
Lorazepam—Coagulopathy—Temozolomide—melanoma	0.00911	0.0122	CcSEcCtD
Lorazepam—Memory impairment—Temozolomide—melanoma	0.00904	0.0121	CcSEcCtD
Lorazepam—Injection site pain—Carmustine—melanoma	0.00899	0.0121	CcSEcCtD
Lorazepam—Liver injury—Temozolomide—melanoma	0.00843	0.0113	CcSEcCtD
Lorazepam—TSPO—neck—melanoma	0.00834	0.0677	CbGeAlD
Lorazepam—Cystitis noninfective—Bleomycin—melanoma	0.00822	0.011	CcSEcCtD
Lorazepam—Cystitis—Bleomycin—melanoma	0.00812	0.0109	CcSEcCtD
Lorazepam—Thinking abnormal—Carmustine—melanoma	0.00802	0.0108	CcSEcCtD
Lorazepam—Leukocytosis—Carmustine—melanoma	0.00781	0.0105	CcSEcCtD
Lorazepam—Bladder pain—Bleomycin—melanoma	0.0076	0.0102	CcSEcCtD
Lorazepam—Injection site reaction—Carmustine—melanoma	0.0073	0.00981	CcSEcCtD
Lorazepam—Respiratory failure—Temozolomide—melanoma	0.00722	0.00971	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Temozolomide—melanoma	0.00709	0.00954	CcSEcCtD
Lorazepam—Urinary incontinence—Carmustine—melanoma	0.00709	0.00953	CcSEcCtD
Lorazepam—Depressed level of consciousness—Carmustine—melanoma	0.00709	0.00953	CcSEcCtD
Lorazepam—Redness—Docetaxel—melanoma	0.00699	0.00939	CcSEcCtD
Lorazepam—Urinary incontinence—Temozolomide—melanoma	0.00685	0.00921	CcSEcCtD
Lorazepam—Depressed level of consciousness—Temozolomide—melanoma	0.00685	0.00921	CcSEcCtD
Lorazepam—Disorientation—Bleomycin—melanoma	0.00682	0.00917	CcSEcCtD
Lorazepam—Coma—Carmustine—melanoma	0.00671	0.00902	CcSEcCtD
Lorazepam—Mental disability—Carmustine—melanoma	0.00637	0.00856	CcSEcCtD
Lorazepam—UGT2B15—Phase II conjugation—UGT2B10—melanoma	0.00632	0.0602	CbGpPWpGaD
Lorazepam—Chills—Vemurafenib—melanoma	0.00625	0.00841	CcSEcCtD
Lorazepam—TSPO—eye—melanoma	0.00621	0.0504	CbGeAlD
Lorazepam—Alopecia—Vemurafenib—melanoma	0.00616	0.00828	CcSEcCtD
Lorazepam—Mental disability—Temozolomide—melanoma	0.00616	0.00827	CcSEcCtD
Lorazepam—TSPO—retina—melanoma	0.00615	0.0499	CbGeAlD
Lorazepam—Erythema—Vemurafenib—melanoma	0.00607	0.00816	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00592	0.00796	CcSEcCtD
Lorazepam—Lethargy—Dactinomycin—melanoma	0.00581	0.00781	CcSEcCtD
Lorazepam—Amnesia—Carmustine—melanoma	0.00567	0.00762	CcSEcCtD
Lorazepam—GABRB3—eye—melanoma	0.00563	0.0457	CbGeAlD
Lorazepam—UGT2B15—Tamoxifen metabolism—CYP1B1—melanoma	0.00558	0.0531	CbGpPWpGaD
Lorazepam—Amnesia—Temozolomide—melanoma	0.00548	0.00737	CcSEcCtD
Lorazepam—TSPO—skin of body—melanoma	0.0054	0.0438	CbGeAlD
Lorazepam—Hyponatraemia—Carmustine—melanoma	0.00535	0.00719	CcSEcCtD
Lorazepam—Diplopia—Carmustine—melanoma	0.00533	0.00716	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00533	0.00716	CcSEcCtD
Lorazepam—Liver function test abnormal—Dactinomycin—melanoma	0.00526	0.00706	CcSEcCtD
Lorazepam—Diplopia—Temozolomide—melanoma	0.00515	0.00692	CcSEcCtD
Lorazepam—Pancytopenia—Bleomycin—melanoma	0.00501	0.00673	CcSEcCtD
Lorazepam—Ataxia—Carmustine—melanoma	0.00501	0.00673	CcSEcCtD
Lorazepam—TSPO—mammalian vulva—melanoma	0.00492	0.04	CbGeAlD
Lorazepam—Infection—Vemurafenib—melanoma	0.00492	0.00661	CcSEcCtD
Lorazepam—Liver function test abnormal—Carmustine—melanoma	0.00492	0.00661	CcSEcCtD
Lorazepam—Ataxia—Temozolomide—melanoma	0.00484	0.00651	CcSEcCtD
Lorazepam—Respiratory failure—Docetaxel—melanoma	0.0048	0.00646	CcSEcCtD
Lorazepam—Hepatocellular injury—Docetaxel—melanoma	0.00472	0.00634	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Docetaxel—melanoma	0.00472	0.00634	CcSEcCtD
Lorazepam—Injection site reaction—Docetaxel—melanoma	0.00469	0.0063	CcSEcCtD
Lorazepam—Pancytopenia—Dactinomycin—melanoma	0.00467	0.00628	CcSEcCtD
Lorazepam—Hypotension—Vemurafenib—melanoma	0.00463	0.00622	CcSEcCtD
Lorazepam—Pancytopenia—Carmustine—melanoma	0.00437	0.00588	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vemurafenib—melanoma	0.00428	0.00575	CcSEcCtD
Lorazepam—Fatigue—Vemurafenib—melanoma	0.00427	0.00574	CcSEcCtD
Lorazepam—Constipation—Vemurafenib—melanoma	0.00424	0.00569	CcSEcCtD
Lorazepam—Pancytopenia—Temozolomide—melanoma	0.00423	0.00568	CcSEcCtD
Lorazepam—Pulmonary oedema—Docetaxel—melanoma	0.0042	0.00564	CcSEcCtD
Lorazepam—GABRG2—head—melanoma	0.00417	0.0338	CbGeAlD
Lorazepam—Erectile dysfunction—Temozolomide—melanoma	0.0041	0.00551	CcSEcCtD
Lorazepam—Agranulocytosis—Dactinomycin—melanoma	0.00409	0.0055	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00394	0.00529	CcSEcCtD
Lorazepam—Chills—Bleomycin—melanoma	0.00379	0.00509	CcSEcCtD
Lorazepam—Alopecia—Bleomycin—melanoma	0.00373	0.00502	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—UGT2B10—melanoma	0.0037	0.0352	CbGpPWpGaD
Lorazepam—GABRA1—head—melanoma	0.00368	0.0299	CbGeAlD
Lorazepam—Erythema—Bleomycin—melanoma	0.00368	0.00494	CcSEcCtD
Lorazepam—Hallucination—Carmustine—melanoma	0.00367	0.00493	CcSEcCtD
Lorazepam—Hypersensitivity—Vemurafenib—melanoma	0.00365	0.0049	CcSEcCtD
Lorazepam—Diclofenac—CXCL8—melanoma	0.00365	0.132	CrCbGaD
Lorazepam—Visual disturbance—Docetaxel—melanoma	0.00361	0.00486	CcSEcCtD
Lorazepam—Asthenia—Vemurafenib—melanoma	0.00355	0.00478	CcSEcCtD
Lorazepam—Visual impairment—Carmustine—melanoma	0.00355	0.00477	CcSEcCtD
Lorazepam—Hallucination—Temozolomide—melanoma	0.00354	0.00476	CcSEcCtD
Lorazepam—Chills—Dactinomycin—melanoma	0.00353	0.00475	CcSEcCtD
Lorazepam—TSPO—head—melanoma	0.00352	0.0286	CbGeAlD
Lorazepam—Lethargy—Docetaxel—melanoma	0.00349	0.0047	CcSEcCtD
Lorazepam—Alopecia—Dactinomycin—melanoma	0.00348	0.00468	CcSEcCtD
Lorazepam—Hyponatraemia—Docetaxel—melanoma	0.00344	0.00462	CcSEcCtD
Lorazepam—Visual impairment—Temozolomide—melanoma	0.00343	0.00461	CcSEcCtD
Lorazepam—Erythema—Dactinomycin—melanoma	0.00343	0.00461	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00342	0.0046	CcSEcCtD
Lorazepam—Arrhythmia—Carmustine—melanoma	0.00329	0.00443	CcSEcCtD
Lorazepam—Dizziness—Vemurafenib—melanoma	0.00328	0.0044	CcSEcCtD
Lorazepam—Alopecia—Carmustine—melanoma	0.00326	0.00438	CcSEcCtD
Lorazepam—Ataxia—Docetaxel—melanoma	0.00322	0.00433	CcSEcCtD
Lorazepam—Erythema—Carmustine—melanoma	0.00321	0.00431	CcSEcCtD
Lorazepam—GABRB3—head—melanoma	0.0032	0.026	CbGeAlD
Lorazepam—Chills—Temozolomide—melanoma	0.0032	0.0043	CcSEcCtD
Lorazepam—Liver function test abnormal—Docetaxel—melanoma	0.00316	0.00425	CcSEcCtD
Lorazepam—Vomiting—Vemurafenib—melanoma	0.00315	0.00423	CcSEcCtD
Lorazepam—Alopecia—Temozolomide—melanoma	0.00315	0.00423	CcSEcCtD
Lorazepam—Rash—Vemurafenib—melanoma	0.00312	0.0042	CcSEcCtD
Lorazepam—Dermatitis—Vemurafenib—melanoma	0.00312	0.00419	CcSEcCtD
Lorazepam—Headache—Vemurafenib—melanoma	0.0031	0.00417	CcSEcCtD
Lorazepam—Erythema—Temozolomide—melanoma	0.0031	0.00417	CcSEcCtD
Lorazepam—Confusional state—Bleomycin—melanoma	0.00303	0.00407	CcSEcCtD
Lorazepam—Vision blurred—Carmustine—melanoma	0.00302	0.00406	CcSEcCtD
Lorazepam—Tremor—Carmustine—melanoma	0.00301	0.00404	CcSEcCtD
Lorazepam—Infection—Bleomycin—melanoma	0.00298	0.00401	CcSEcCtD
Lorazepam—Agitation—Carmustine—melanoma	0.00295	0.00396	CcSEcCtD
Lorazepam—Nausea—Vemurafenib—melanoma	0.00294	0.00395	CcSEcCtD
Lorazepam—Thrombocytopenia—Bleomycin—melanoma	0.00294	0.00395	CcSEcCtD
Lorazepam—Vision blurred—Temozolomide—melanoma	0.00292	0.00393	CcSEcCtD
Lorazepam—Tremor—Temozolomide—melanoma	0.00291	0.00391	CcSEcCtD
Lorazepam—Agitation—Temozolomide—melanoma	0.00285	0.00383	CcSEcCtD
Lorazepam—Pancytopenia—Docetaxel—melanoma	0.00281	0.00378	CcSEcCtD
Lorazepam—Hypotension—Bleomycin—melanoma	0.0028	0.00377	CcSEcCtD
Lorazepam—Vertigo—Temozolomide—melanoma	0.00279	0.00374	CcSEcCtD
Lorazepam—Convulsion—Carmustine—melanoma	0.00278	0.00374	CcSEcCtD
Lorazepam—Infection—Dactinomycin—melanoma	0.00278	0.00374	CcSEcCtD
Lorazepam—Hypertension—Carmustine—melanoma	0.00277	0.00372	CcSEcCtD
Lorazepam—Thrombocytopenia—Dactinomycin—melanoma	0.00274	0.00368	CcSEcCtD
Lorazepam—Convulsion—Temozolomide—melanoma	0.00269	0.00361	CcSEcCtD
Lorazepam—Hypertension—Temozolomide—melanoma	0.00268	0.0036	CcSEcCtD
Lorazepam—Confusional state—Carmustine—melanoma	0.00264	0.00355	CcSEcCtD
Lorazepam—Infection—Carmustine—melanoma	0.0026	0.0035	CcSEcCtD
Lorazepam—Dry mouth—Temozolomide—melanoma	0.00258	0.00347	CcSEcCtD
Lorazepam—Jaundice—Docetaxel—melanoma	0.00257	0.00346	CcSEcCtD
Lorazepam—Pain—Bleomycin—melanoma	0.00257	0.00345	CcSEcCtD
Lorazepam—Thrombocytopenia—Carmustine—melanoma	0.00256	0.00345	CcSEcCtD
Lorazepam—Tachycardia—Carmustine—melanoma	0.00256	0.00344	CcSEcCtD
Lorazepam—Confusional state—Temozolomide—melanoma	0.00255	0.00343	CcSEcCtD
Lorazepam—Infection—Temozolomide—melanoma	0.00251	0.00338	CcSEcCtD
Lorazepam—Thrombocytopenia—Temozolomide—melanoma	0.00248	0.00333	CcSEcCtD
Lorazepam—Feeling abnormal—Bleomycin—melanoma	0.00247	0.00332	CcSEcCtD
Lorazepam—TSPO—lymph node—melanoma	0.00247	0.02	CbGeAlD
Lorazepam—Agranulocytosis—Docetaxel—melanoma	0.00246	0.00331	CcSEcCtD
Lorazepam—Hypotension—Carmustine—melanoma	0.00245	0.00329	CcSEcCtD
Lorazepam—Fatigue—Dactinomycin—melanoma	0.00241	0.00324	CcSEcCtD
Lorazepam—Pain—Dactinomycin—melanoma	0.00239	0.00322	CcSEcCtD
Lorazepam—Somnolence—Carmustine—melanoma	0.00233	0.00313	CcSEcCtD
Lorazepam—Feeling abnormal—Dactinomycin—melanoma	0.00231	0.0031	CcSEcCtD
Lorazepam—Visual impairment—Docetaxel—melanoma	0.00228	0.00307	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Carmustine—melanoma	0.00226	0.00304	CcSEcCtD
Lorazepam—Somnolence—Temozolomide—melanoma	0.00225	0.00302	CcSEcCtD
Lorazepam—Pain—Carmustine—melanoma	0.00224	0.00301	CcSEcCtD
Lorazepam—Constipation—Carmustine—melanoma	0.00224	0.00301	CcSEcCtD
Lorazepam—Hypersensitivity—Bleomycin—melanoma	0.00221	0.00297	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Temozolomide—melanoma	0.00219	0.00294	CcSEcCtD
Lorazepam—GABRB3—Orphan transporters—ARL2—melanoma	0.00218	0.0208	CbGpPWpGaD
Lorazepam—Fatigue—Temozolomide—melanoma	0.00218	0.00293	CcSEcCtD
Lorazepam—Constipation—Temozolomide—melanoma	0.00216	0.00291	CcSEcCtD
Lorazepam—Pain—Temozolomide—melanoma	0.00216	0.00291	CcSEcCtD
Lorazepam—Feeling abnormal—Carmustine—melanoma	0.00216	0.0029	CcSEcCtD
Lorazepam—Asthenia—Bleomycin—melanoma	0.00215	0.00289	CcSEcCtD
Lorazepam—GABRG2—Orphan transporters—ARL2—melanoma	0.00214	0.0204	CbGpPWpGaD
Lorazepam—Chills—Docetaxel—melanoma	0.00213	0.00286	CcSEcCtD
Lorazepam—Arrhythmia—Docetaxel—melanoma	0.00212	0.00284	CcSEcCtD
Lorazepam—Alopecia—Docetaxel—melanoma	0.00209	0.00281	CcSEcCtD
Lorazepam—Feeling abnormal—Temozolomide—melanoma	0.00209	0.0028	CcSEcCtD
Lorazepam—Erythema—Docetaxel—melanoma	0.00206	0.00277	CcSEcCtD
Lorazepam—Hypersensitivity—Dactinomycin—melanoma	0.00206	0.00277	CcSEcCtD
Lorazepam—Asthenia—Dactinomycin—melanoma	0.00201	0.0027	CcSEcCtD
Lorazepam—Hypersensitivity—Carmustine—melanoma	0.00193	0.00259	CcSEcCtD
Lorazepam—Vomiting—Bleomycin—melanoma	0.00191	0.00256	CcSEcCtD
Lorazepam—Rash—Bleomycin—melanoma	0.00189	0.00254	CcSEcCtD
Lorazepam—Dermatitis—Bleomycin—melanoma	0.00189	0.00254	CcSEcCtD
Lorazepam—Asthenia—Carmustine—melanoma	0.00188	0.00253	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—ARL2—melanoma	0.00187	0.0178	CbGpPWpGaD
Lorazepam—Hypersensitivity—Temozolomide—melanoma	0.00186	0.00251	CcSEcCtD
Lorazepam—Asthenia—Temozolomide—melanoma	0.00182	0.00244	CcSEcCtD
Lorazepam—Convulsion—Docetaxel—melanoma	0.00179	0.0024	CcSEcCtD
Lorazepam—Nausea—Bleomycin—melanoma	0.00178	0.0024	CcSEcCtD
Lorazepam—Hypertension—Docetaxel—melanoma	0.00178	0.00239	CcSEcCtD
Lorazepam—Vomiting—Dactinomycin—melanoma	0.00178	0.00239	CcSEcCtD
Lorazepam—Rash—Dactinomycin—melanoma	0.00176	0.00237	CcSEcCtD
Lorazepam—Dizziness—Carmustine—melanoma	0.00173	0.00233	CcSEcCtD
Lorazepam—Dry mouth—Docetaxel—melanoma	0.00172	0.00231	CcSEcCtD
Lorazepam—Confusional state—Docetaxel—melanoma	0.0017	0.00228	CcSEcCtD
Lorazepam—Dizziness—Temozolomide—melanoma	0.00167	0.00225	CcSEcCtD
Lorazepam—Infection—Docetaxel—melanoma	0.00167	0.00225	CcSEcCtD
Lorazepam—Vomiting—Carmustine—melanoma	0.00167	0.00224	CcSEcCtD
Lorazepam—Nausea—Dactinomycin—melanoma	0.00166	0.00223	CcSEcCtD
Lorazepam—Clozapine—CYP1B1—melanoma	0.00166	0.0601	CrCbGaD
Lorazepam—Rash—Carmustine—melanoma	0.00165	0.00222	CcSEcCtD
Lorazepam—Dermatitis—Carmustine—melanoma	0.00165	0.00222	CcSEcCtD
Lorazepam—Thrombocytopenia—Docetaxel—melanoma	0.00165	0.00221	CcSEcCtD
Lorazepam—Tachycardia—Docetaxel—melanoma	0.00164	0.00221	CcSEcCtD
Lorazepam—Headache—Carmustine—melanoma	0.00164	0.00221	CcSEcCtD
Lorazepam—Vomiting—Temozolomide—melanoma	0.00161	0.00216	CcSEcCtD
Lorazepam—Rash—Temozolomide—melanoma	0.0016	0.00214	CcSEcCtD
Lorazepam—Dermatitis—Temozolomide—melanoma	0.00159	0.00214	CcSEcCtD
Lorazepam—Headache—Temozolomide—melanoma	0.00159	0.00213	CcSEcCtD
Lorazepam—Hypotension—Docetaxel—melanoma	0.00157	0.00211	CcSEcCtD
Lorazepam—Nausea—Carmustine—melanoma	0.00156	0.00209	CcSEcCtD
Lorazepam—Nausea—Temozolomide—melanoma	0.0015	0.00202	CcSEcCtD
Lorazepam—Somnolence—Docetaxel—melanoma	0.0015	0.00201	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00148	0.0141	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Docetaxel—melanoma	0.00145	0.00195	CcSEcCtD
Lorazepam—Fatigue—Docetaxel—melanoma	0.00145	0.00195	CcSEcCtD
Lorazepam—Pain—Docetaxel—melanoma	0.00144	0.00193	CcSEcCtD
Lorazepam—Constipation—Docetaxel—melanoma	0.00144	0.00193	CcSEcCtD
Lorazepam—Feeling abnormal—Docetaxel—melanoma	0.00139	0.00186	CcSEcCtD
Lorazepam—Hypersensitivity—Docetaxel—melanoma	0.00124	0.00167	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—CYP17A1—melanoma	0.00123	0.0117	CbGpPWpGaD
Lorazepam—Asthenia—Docetaxel—melanoma	0.00121	0.00162	CcSEcCtD
Lorazepam—Dizziness—Docetaxel—melanoma	0.00111	0.0015	CcSEcCtD
Lorazepam—Vomiting—Docetaxel—melanoma	0.00107	0.00144	CcSEcCtD
Lorazepam—Diclofenac—PTGS2—melanoma	0.00106	0.0385	CrCbGaD
Lorazepam—Rash—Docetaxel—melanoma	0.00106	0.00143	CcSEcCtD
Lorazepam—Dermatitis—Docetaxel—melanoma	0.00106	0.00143	CcSEcCtD
Lorazepam—Headache—Docetaxel—melanoma	0.00105	0.00142	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—CYP1B1—melanoma	0.00104	0.00987	CbGpPWpGaD
Lorazepam—Nausea—Docetaxel—melanoma	0.001	0.00134	CcSEcCtD
Lorazepam—Clonazepam—ALB—melanoma	0.000988	0.0358	CrCbGaD
Lorazepam—Diclofenac—ALB—melanoma	0.000947	0.0343	CrCbGaD
Lorazepam—Diclofenac—ABCB1—melanoma	0.000904	0.0327	CrCbGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—SLC6A11—melanoma	0.000857	0.00815	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—MAP2—melanoma	0.00085	0.00809	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—SLC6A11—melanoma	0.000841	0.008	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCB5—melanoma	0.000769	0.00731	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000755	0.00718	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—BCL2L11—melanoma	0.000747	0.00711	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—SLC6A11—melanoma	0.000735	0.007	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TP73—melanoma	0.000723	0.00688	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.000696	0.00662	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACER3—melanoma	0.000692	0.00658	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.000684	0.0065	CbGpPWpGaD
Lorazepam—Nitrazepam—ABCB1—melanoma	0.000683	0.0247	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00066	0.00628	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—SLC6A11—melanoma	0.000656	0.00624	CbGpPWpGaD
Lorazepam—Chlorprothixene—ABCB1—melanoma	0.000651	0.0236	CrCbGaD
Lorazepam—GABRG2—Neuronal System—SLC6A11—melanoma	0.000645	0.00613	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CDH2—melanoma	0.00064	0.00609	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—UGT2B10—melanoma	0.000633	0.00602	CbGpPWpGaD
Lorazepam—Flurazepam—ABCB1—melanoma	0.000608	0.022	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.000598	0.00568	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HS3ST5—melanoma	0.000588	0.0056	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—SLC6A11—melanoma	0.000563	0.00536	CbGpPWpGaD
Lorazepam—Midazolam—ABCB1—melanoma	0.000563	0.0204	CrCbGaD
Lorazepam—GABRB3—BDNF signaling pathway—PTK2B—melanoma	0.000544	0.00518	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ARL2—melanoma	0.000533	0.00507	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000523	0.00498	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ARL2—melanoma	0.000523	0.00498	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000514	0.00489	CbGpPWpGaD
Lorazepam—Diazepam—ALB—melanoma	0.000506	0.0183	CrCbGaD
Lorazepam—Diazepam—ABCB1—melanoma	0.000483	0.0175	CrCbGaD
Lorazepam—Clozapine—ABCB1—melanoma	0.000477	0.0173	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ARL2—melanoma	0.000457	0.00435	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NGFR—melanoma	0.000454	0.00432	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000449	0.00427	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLCB4—melanoma	0.000446	0.00424	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIP4K2A—melanoma	0.000419	0.00399	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC6A11—melanoma	0.000419	0.00399	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTAP—melanoma	0.000408	0.00388	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000404	0.00384	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIN2A—melanoma	0.000401	0.00381	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000397	0.00377	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIN2A—melanoma	0.000394	0.00375	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000389	0.0037	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000382	0.00363	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.000366	0.00348	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LUM—melanoma	0.000363	0.00346	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PHGDH—melanoma	0.000363	0.00346	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.000359	0.00342	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HPSE—melanoma	0.000356	0.00339	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000353	0.00336	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—SPP1—melanoma	0.000351	0.00334	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CUBN—melanoma	0.00035	0.00333	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAP2K2—melanoma	0.00035	0.00333	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000347	0.0033	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000347	0.0033	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIN2A—melanoma	0.000344	0.00327	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SDHD—melanoma	0.000338	0.00321	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—BSG—melanoma	0.000338	0.00321	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CSPG4—melanoma	0.000338	0.00321	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000334	0.00317	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—RAC1—melanoma	0.000332	0.00315	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPAM—melanoma	0.000327	0.00311	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.000314	0.00299	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL10—melanoma	0.000304	0.00289	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000303	0.00288	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—APC—melanoma	0.00028	0.00266	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLA2G6—melanoma	0.000278	0.00265	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—PRKCA—melanoma	0.000275	0.00262	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—PRKCA—melanoma	0.00027	0.00257	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.000269	0.00256	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.000264	0.00252	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000256	0.00243	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—VCAN—melanoma	0.00025	0.00238	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAP2K1—melanoma	0.000248	0.00236	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PRKCA—melanoma	0.000236	0.00224	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.000231	0.0022	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000226	0.00215	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000222	0.00211	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP17A1—melanoma	0.000211	0.00201	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—PRKCA—melanoma	0.000211	0.002	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—PRKCA—melanoma	0.000207	0.00197	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—BRAF—melanoma	0.000202	0.00193	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GNA11—melanoma	0.000199	0.00189	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—BRAF—melanoma	0.000199	0.00189	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CASP3—melanoma	0.000197	0.00188	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—FASN—melanoma	0.000195	0.00185	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000194	0.00184	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC5A5—melanoma	0.000192	0.00182	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CTNNB1—melanoma	0.00019	0.00181	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GNAQ—melanoma	0.000185	0.00176	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CD44—melanoma	0.000185	0.00176	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NFKB1—melanoma	0.000185	0.00176	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PRKCA—melanoma	0.000181	0.00172	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP1B1—melanoma	0.000177	0.00169	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—BRAF—melanoma	0.000174	0.00165	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—MDM2—melanoma	0.00017	0.00161	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—MDM2—melanoma	0.000167	0.00158	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000166	0.00158	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—STAT3—melanoma	0.000166	0.00158	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000161	0.00154	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000159	0.00151	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000158	0.00151	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK3—melanoma	0.000158	0.00151	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—BRAF—melanoma	0.000155	0.00148	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000154	0.00147	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000153	0.00146	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—BRAF—melanoma	0.000152	0.00145	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000151	0.00144	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK1—melanoma	0.000151	0.00143	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000149	0.00141	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCB1—melanoma	0.000146	0.00139	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	0.000146	0.00138	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000139	0.00132	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000135	0.00128	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PRKCA—melanoma	0.000135	0.00128	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ERCC2—melanoma	0.000133	0.00127	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—BRAF—melanoma	0.000133	0.00127	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000132	0.00126	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—MDM2—melanoma	0.00013	0.00124	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—MDM2—melanoma	0.000128	0.00121	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000124	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000123	0.00117	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000122	0.00116	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—HRAS—melanoma	0.000121	0.00115	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	0.000121	0.00115	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—melanoma	0.000116	0.0011	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	0.000116	0.0011	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000114	0.00108	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—MDM2—melanoma	0.000112	0.00106	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—melanoma	0.000107	0.00102	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000106	0.00101	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000106	0.001	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CG—melanoma	0.000105	0.001	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARG—melanoma	0.000102	0.000967	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	9.95e-05	0.000947	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	9.33e-05	0.000887	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—HRAS—melanoma	9.31e-05	0.000885	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CD—melanoma	9.26e-05	0.000881	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALB—melanoma	9.14e-05	0.00087	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	9.14e-05	0.000869	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—MAPK1—melanoma	8.88e-05	0.000845	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—MAPK1—melanoma	8.72e-05	0.00083	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CB—melanoma	8.07e-05	0.000768	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—melanoma	8e-05	0.000761	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	7.99e-05	0.00076	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ALB—melanoma	7.7e-05	0.000732	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—MAPK1—melanoma	7.62e-05	0.000725	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	7.56e-05	0.000719	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—HRAS—melanoma	7.13e-05	0.000678	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—HRAS—melanoma	7e-05	0.000666	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTEN—melanoma	6.98e-05	0.000664	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	6.61e-05	0.000629	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—HRAS—melanoma	6.12e-05	0.000582	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CA—melanoma	4.92e-05	0.000468	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—melanoma	4.02e-05	0.000382	CbGpPWpGaD
